Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol 1995;25: 516.

Waller BF, Pinkerton CA, Orr CM, et al. Restenosis 1to 24 months after clinical successful coronary balloon angioplasty: A necropsy study of 20 patients. J Am Col-loardiol 1991; 17: 58B-70B.

O’Brien ER, Alpens CE, Stewart DK, et al. Hyperpla-sia in primary and restenotic coronary atherectomy tissue implications for antiproliferative therapy. Cir Res 1993;73: 223–231.

Mintz GS, Popma JJ, Pichard AD, et al. Arterial re-odeling after coronary angioplasty: A serial intravascu-lar ultrasound study. Circulation 1996;94: 35–43.

Gruberg L, Waksman R, Satler LF, et al. Novel ap-proaches for the prevention of restenosis. Expert Opin Investig Drugs 2000;9(11): 2555–2578.

Faxon DP, Borst C. Remodeling: historical perspectives and definition of terms. Semin Interv Cardiol 1997; 2(3): 145–146.

Quarck R, Holvoet P. Restenosis and gene therapy. Expert Opin Biol Ther 2001; 1(1): 79–91.

Glagov S. Intimai hyperplasia, vascular modeling, and the restenosis problem. Circulation 1994;89: 2888.

Lijnen HR. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001; 86(1): 324–333.

Pan XM, Wu ZG. Restenosis and vascular remodeling after coronary angioplasty. For Med Cardiovas Dis Fasc 1999;26(2): 78–81.

Cai X, Gong LS. Vascular remodeling, tunica adventitia and restenosis after coronary artery intervention. For Med Internal Med Fasc 1999;26(2): 54–57,92.

Gong Y, Zhu DL. Mechanisms of tunica adventitia in vascular remodeling. For Med Pathol Clin Med Fasc 1999;19(6): 516–518.

Durand E, Mallat Z, Addad F, et al. Time courses of apoptosis and cell hyperplasia and their relationship to arterial remodeling and restenosis after angioplasty in an atherosclerotic rabbit model. J Am Coll Cardiol 2002;39 (10): 1680–1685.

Hyman KM, Seghezzi G, Pintucci G, et al. Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated pro-tein kinase. Surgery 2002; 132(2): 173–179.

Ibe W, Bartels W, Lindemann S, et al. Involvement of PKC and NF-kappaB in nitric oxide induced apoptosis in human coronary artery smooth muscle cells. Cell Physiol Biochem 2001, 11(5): 231–240.

Galis ZS, Johnson C, Godin D, et al. Targeted disrup-tion of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial re-modeling. Circ Res 2002; 91(9): 852–859.

Orbe J, Rodriguez JA, Arias R, et al. Antioxidant vita-mins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis 2003; 167(1): 45 -53.

Lu SZ, Chen YD. Diganosing skill and device selection in coronary artery intervention. 1st ed. Beijing: Peoplés Medical Publishing House, 2003: 243–253, 286–293, 294–305.

Xu H, Shi DZ, Chen KJ, et al. Clinical study of Xiong-shao capsule on preventing restenosis after coronary in-terventional treatment. Chin J Integr Tradit West Med2000;20(7): 494–497.

Shi DZ, Xu FQ, Ma XC, et al. Study of concentrated Xuefu Zhuyu Pill on preventing restenosis in rabbits after percutaneous transluminal coronary angioplasty. J TCM1997;38(11): 685–687.

Zhou XM, Lu ZY, Wang DW. Preliminary study of Sal-via miltiorrhiza on preventing experimental coronary restenosis and its mechanism. Chin J Integr Tradit WestMed 1996;16(8): 480–482.

Xia H, Li GS, Xu JL, et al. The effect of Notoginseng saponins on rabbits’ c-myc gene expression and SMC pro-liferation after carotid artery endepidermis. Chin J Inter-vent Cardiol 1997;5(1): 45–47.

Liu CY, Zhang YH, Guan SM, et al. The effect of pu-erarin to collagen hyperplasia of I after vascular endepi-dermis. Clin J Cardiovasc Dis 1997; 13(3): 176–177.

Tang LL, Wang LH, Zhang JH, et al. The effect of Li-gustrazine collagen gene expression of primary passage cultured vascular smooth muscle cell. Chin J Integr Tra-dit West Med 1995;15(11): 666–668.

Yan YZ, Chen XY, Wu KJ, et al. The effect of ligus-trazine and 764–3 to procollagen mRNA expression of fi-broblast I and IE. Chin Acad J Med Sci 1996; 18(2): 126–128.

Shi ZX, Du JH. Minutes of international conference of “blood-stasis syndrome” general survey and summary of the 4th national “Huoxue Huayu” academic conference. Chin J Integr Tradit West Med 1995; 15 (12): 755 -757.

Su JW, Wu WK, Lin SG, et al. Improving effect of Sini decoction to patients’ hemorrheology after PTCA. Chin J Integr Tradit West Med 1997;17(6): 345–347.

Xu H, Shi DZ, Chen KJ, et al. Effect of Xiongshao Capsule on vascular remodeling in porcine coronary bal-loon injury model. Chin J Integr Tradit West Med 2001;21(8): 591–594.

Xu H, Shi DZ, Chen KJ, et al. Effects of XS0601 on porcine intima apoptosis and relative gene expression of bcl-2 and p53 after coronary artery balloon injury. Chin J Interv Cardiol 2001;9(3): 152–154.

Xu H, Shi DZ, Chen KJ, et al. Effect of Xiongshao capsule on SMC proliferation and apoptosis in rabbits’ thoracic aorta by serum pharmacologic method. Chin J Integr Tradit West Med 2000;20(10): 757–760.

Liu HB, Wen JK, Han M. Effects of Salvia miltiorrhiza on matrix metalloproteinases and osteopontin gene expression and proliferation of cultured vascular smooth muscle cells. Chin J Integr Tradit West Med 2002; 22 (10): 764–766.

Li QP, Lu ZA, Rao MR. Tetrandrine inhibits collagen synthesis of vascular smooth muscle cell. Acta Pharmaceutica Sinica 2001;36(7): 481–484.

Li DG, Li JX, Li ZB, et al. Protection of tetrandrine on restenosis after vascualr endepidermis and its molecule mechanism. J Hebei Med Univ 2002;23(2): 68–70.